Skip to content
Clinical Trials – home
Verifiedinfo

Klinikum Klagenfurt am Wörthersee

Austria Feschnigstrasse 11, 9020 Klagenfurt am Wörthersee, Austria

  • 3 trials recruiting
  • Migraine · Pulmonary hypertension · Proctitis
  • Adult patients

About Specializations

Klinikum Klagenfurt am Wörthersee in Klagenfurt am Wörthersee, Austria specialises in clinical trials of conditions such as Migraine, Pulmonary hypertension, Proctitis, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Male Urogenital Diseases

At Klinikum Klagenfurt am Wörthersee, clinical research in neoplasms focuses on early breast cancer and prostate carcinoma, with studies aimed at improving long-term cancer control and easing treatment-related complications.

  • Testing a new endocrine-based approach to help prevent recurrence in ER+/HER2- early breast cancer
  • Evaluating a rectal therapy to relieve acute radiation proctitis symptoms in men treated for prostate cancer

These studies reflect a strong interest in both cancer recurrence prevention and supportive care for patients experiencing side effects from radiation treatment.

Nervous System Diseases

The site is also active in nervous system diseases, especially migraine, where trials are examining better ways to prevent attacks and provide faster relief during episodes.

  • Assessing a preventive treatment for adults with frequent migraine attacks and limited response to prior therapies
  • Comparing an acute treatment option with placebo to improve migraine headache pain relief

These studies aim to improve both day-to-day migraine control and treatment options for people who do not respond well to standard medications.

Cardiovascular Diseases

Research in cardiovascular diseases at the department includes work on pulmonary hypertension linked with heart failure with preserved ejection fraction, a complex condition that can severely limit exercise capacity and quality of life.

  • Evaluating whether a new treatment can improve walking distance and physical function in PH-HFpEF
  • Assessing the safety and tolerability of a therapy intended to support patients with advanced cardiopulmonary symptoms

This line of research is centered on improving symptoms, exercise tolerance, and treatment safety in a challenging heart-lung disorder.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Feschnigstrasse 119020 Klagenfurt am WörtherseeAustria
Recruiting now
3 trials
Conditions studied
3
Partner status
Verified

More sites in Klagenfurt am WörtherseeAustria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Tenax Therapeutics Inc.

Proctitis

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Dr. Falk Pharma GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Migraine

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.